Inventor
LANGE MARTIN
DE22 patents
⚠️ This page may combine multiple inventors who share the name “LANGE MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
10 patentsUS10308634B2Jun 4, 2019
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
Bayer Pharma AG17 citations93
US9951086B2Apr 24, 2018
Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments
Bayer Pharma AG21 citations84
US10793545B2Oct 6, 2020
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
Bayer Pharma AG7 citations82
US12006304B2Jun 11, 2024
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs
Bayer Pharma AG1 citations71
US12006303B2Jun 11, 2024
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs
Bayer Pharma AG1 citations71
US10435396B2Oct 8, 2019
2-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugs
Bayer Pharma AG7 citations71
US10925880B2Feb 23, 2021
Combination of PI3K-inhibitors
Bayer Pharma AG0 citations62
US12559473B2Feb 24, 2026
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
Bayer Pharma AG0 citations61
US12053476B2Aug 6, 2024
Compounds, compositions and methods for cancer patient stratification and cancer treatment
Bayer Pharma AG0 citations60
US10966986B2Apr 6, 2021
Compounds, compositions and methods for cancer patient stratification and cancer treatment
Bayer Pharma AG1 citations60
BAYER AG
4 patentsUS11773070B2Oct 3, 2023
Dihydrooxadiazinones
BAYER AG2 citations72
US11427553B2Aug 30, 2022
Dihydrooxadiazinones
BAYER AG4 citations72
US12258323B2Mar 25, 2025
Dihydrooxadiazinones
BAYER AG1 citations63
US12427153B2Sep 30, 2025
1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases
BAYER AG0 citations51